Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-23 Sale | 2024-08-27 6:46 pm | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 164,686 | $5.7814 | $952,116 | 447,530 (Direct) | View |
| 2021-09-23 Purchase | 2021-09-27 5:22 pm | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 4,716 | $7.4757 | $35,255 | 4,716 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-12 Option Award | 2025-02-11 5:54 pm | N/A 2034-01-12 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 302,500 | $0 | 302,500 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 13,125 | $1.81 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 25,000 | $3.27 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 64,166 | $2.49 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A 2032-01-17 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 157,186 | $0 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 54,895 | $4.85 | 447,530 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:01 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 430,000 | $0 | 430,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 5:15 pm | N/A 2033-02-01 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 4:30 pm | N/A 2032-07-24 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 4:25 pm | N/A 2032-01-17 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-09-07 Option Award | 2021-09-09 5:21 pm | N/A 2031-09-06 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 5:47 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks | 67,700 | $0 | 67,700 (Direct) | View |